Remedium Lifecare Peer Comparison

BSE: 539561

₹0.30

₹0.01 (3.45%)

As on 28-Aug-2026IST

Market cap

₹26 Cr

Revenue (TTM)

₹147 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Market cap (₹ Cr)	26	38,731	21,501	19,125	18,253
Revenue (₹ Cr)	147	4,148	2,570	2,287	3,230
Net Profit (₹ Cr)	-2.17	709.47	735.15	678.07	666.92
Net Margin (%)	-1.34	16.85	26.88	28.10	20.60
RoE (%)	-3.24	19.11	19.16	19.73	18.75
Price to Earnings	--	54.59	29.25	28.74	28.35
Price-To-Book	0.29	9.31	4.88	5.08	4.51

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Operating Revenue	405.25	3,917.99	2,281.35	1,937.47	2,893.64
Total Income	416.05	3,957.03	2,453.60	2,033.90	2,912.00
Total Expenditure	403.99	2,886.87	1,541.03	1,290.54	1,876.44
EBITDA	1.26	1,031.12	740.32	646.93	1,017.20
Depreciation	0.04	171.04	60.79	65.96	315.46
EBIT	1.22	860.08	679.53	580.97	701.74
Interest	7.64	11.73	8.50	0.61	231.29
Other Income	10.80	39.04	172.25	96.43	18.36
Exceptional Items	--	--	172.81	--	--
Profit before Tax	4.38	887.39	1,016.09	676.78	488.87
Provision for Tax	2.26	227.81	248.49	135.69	114.20
Profit after Tax	2.13	659.58	767.60	541.09	374.67

Liabilities (₹ Cr)

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Shareholder's Funds	43.89	3,433.32	4,217.41	2,850.49	2,854.36
Minority Interest	--	--	--	35.90	417.40
Non-Current Liabilities	-0.04	443.23	54.89	13.24	2,100.97
Current Liabilities	1,676.46	1,156.93	569.51	305.99	1,489.55
Total Liabilities	1,720.35	5,033.48	4,911.11	3,207.85	6,862.28

Assets (₹ Cr)

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Non-Current Assets	0.01	2,586.15	1,328.96	1,071.67	5,531.13
Current Assets	1,720.31	2,447.33	3,512.85	2,133.95	1,331.15
Total Assets	1,720.35	5,033.48	4,911.11	3,207.85	6,862.28
Total Debt*	1,141.39	13.80	2.50	0.55	2,421.66
Net Current Assets	43.85	1,290.40	2,943.34	1,827.96	-158.40
Contingent Liabilities	--	131.94	363.79	0.64	64.29

Cashflow (₹ Cr)

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Cash From Operating Activities	-1,134.81	902.45	659.75	432.37	1,065.01
Cash Flow from Investing Activities	0.13	-295.90	-71.34	-334.73	-79.97
Cash from Financing Activities	1,136.10	-579.67	-205.34	-38.32	-881.32
Net Cash Inflow / Outflow	1.43	26.88	383.07	59.32	103.72

Ratios

Profitability Ratios

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
ROCE (%)	1.01	26.73	26.21	26.22	13.59
ROE (%)	4.85	21.81	19.65	21.72	13.81
ROA (%)	0.12	13.58	17.03	18.37	5.48
EBIT Margin (%)	2.98	27.31	40.00	38.37	35.79
Net Margin (%)	0.51	16.67	31.28	26.60	12.87
Cash Profit Margin (%)	0.54	20.46	34.70	31.33	23.22

Growth Ratios

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Revenue Growth (%)	0.00	12.45	4.02	14.37	44.02
EBIT Growth (%)	591.52	14.56	11.86	20.21	48.22
Net Profit Growth (%)	0.00	19.35	39.23	17.27	-5.65
EPS Growth (%)	0.00	18.98	39.23	17.25	-10.39
Book Value Growth (%)	0.00	17.31	17.30	23.77	10.19

Valuation Ratios

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Price / Earnings	24.06	38.29	23.86	28.38	54.83
Price / Book Value	1.67	7.73	4.34	5.52	6.78
Dividend Yield (%)	0.00	0.96	4.12	0.30	0.52
EV/EBITDA	100.58	23.49	17.01	19.78	20.75
Market Cap (₹ Cr)	73.39	25,253.79	18,318.10	15,219.80	19,292.77

Solvency Ratios

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Debt to Equity	26.01	0.00	0.00	0.00	0.85
Short term debt to equity ratio	26.01	0.00	0.00	0.00	0.14
Current Ratio	1.03	2.12	6.17	6.97	0.89
Quick Ratio	0.87	1.66	5.33	5.88	0.67
Interest Coverage	1.57	76.66	120.54	1,110.48	3.11

Operating Efficiency Ratios

	Remedium Lifecare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Debtors to sales (%)	190.41	20.81	8.46	32.65	15.85
Asset Turnover	0.24	0.84	0.53	0.66	0.43
Receivable days	694.98	67.54	29.10	110.70	54.07
Inventory Days	242.62	46.37	69.53	65.86	32.16
Payable days	459.27	106.33	76.77	105.88	140.91
Cash Conversion Cycle	478.33	7.58	21.86	70.68	-54.68

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.